ArticleAnnals of the rheumatic diseases2014

An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).

Carol A Langford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.